EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Omega‐3 Supplementation in Sarcopenia After Bariatric Surgery: A Triple‐Blind Randomized Controlled Clinical Trial

André Vicente Bigolin iD, Júlia Iaroseski iD, Randhall Bruce Carteri iD, Giovanna Severino Rodrigues iD, Rafaela de Andrade iD, Luiz Alberto De Carli iD, Elisa Loch Razzera iD, Izabele Vian iD, Roberta de Almeida da Silva iD, Antônio Nocchi Kalil iD, Luis Fernando Ferreira iD

Journal of Cachexia, Sarcopenia and Muscle · 2026-06 · 17 (3)

DOI: 10.1002/jcsm.70321 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 14.06.2026. Verfasst von André Vicente Bigolin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Santa Casa of Porto Alegre Hospital, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Dietary Supplements, Fatty Acids, Omega-3, Bariatric Surgery, Sarcopenia. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bariatric surgery is an effective treatment for obesity but induces substantial muscle loss, potentially leading to sarcopenia. Omega‐3 fatty acids have been associated with improved muscle metabolism, but their effect in the postoperative period of bariatric surgery remains unclear.

Methods

A triple‐blind randomized clinical trial following CONSORT guidelines. Patients undergoing bariatric surgery were randomly assigned to receive omega‐3 supplementation (2000 mg/day of EPA + DHA) or placebo (sunflower oil) for 90 days, including 15 days preoperatively and 75 days postoperatively. Assessments were performed at baseline, 45 days and 105 days after the start of supplementation. Outcomes included skeletal muscle mass (bioelectrical impedance [BIA]), handgrip strength (HGS) and functional performance (timed up and go [TUG] test).

Results

Fifty‐eight patients were randomized (81% women; mean age 38.2 ± 9.9 years; mean body mass index [BMI]: 41.1 ± 4.6 kg/m 2 ). At baseline, intervention and control groups were comparable in weight (112.7 ± 19.1 vs. 113.0 ± 17.9 kg; p = 0.946), muscle mass (33.5 ± 7.5 vs. 32.5 ± 7.3 kg; p = 0.603), HGS (33.3 ± 9.6 vs. 35.4 ± 10.2 kgf; p = 0.428) and TUG (8.7 ± 3.0 vs. 8.7 ± 1.8 s; p = 0.912). Between baseline and 105 days, muscle mass decreased significantly in both groups (−3.1 ± 0.3 kg; −2.2 ± 0.5 kg; both p < 0.001), without interaction between groups ( p = 0.300). HGS remained stable (Δ −0.8 to +2.3 kgf; all p ≥ 0.364), and TUG performance did not change significantly (Δ 0.0–1.1 s; all p ≥ 0.106). Weight loss was marked in both groups (−19.3 ± 1.9 vs. −17.7 ± 2.1 kg; both p < 0.001). The incidence of gastrointestinal symptoms ≥ 3 times/week was similar (34.5% vs. 13.6% at 45 days; p = 0.114). No serious adverse events occurred.

Conclusions

Omega‐3 supplementation (2000 mg/day) during the perioperative period of bariatric surgery did not prevent muscle mass loss nor improve muscle strength or functional performance within 105 days of follow‐up. Although the supplementation was safe and well tolerated, it did not demonstrate efficacy in mitigating early sarcopenia‐related outcomes in this population. Trial Registration: ClinicalTrials.gov: NCT06494566

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsFatty Acids, Omega-3Bariatric SurgerySarcopeniaHumansFemaleAdultMaleMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

bariatric surgerydietary supplementsmuscle strengthomega‐3 fatty acidssarcopenia

Substanzen

Fatty Acids, Omega-3

Autor:innen und Institutionen

  • Santa Casa of Porto Alegre Hospital, Porto Alegre, Brazil.
  • Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology, Porto Alegre, Brazil.
  • Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
  • Queen's University of Belfast, Belfast, UK.

ORCID-Profile: André Vicente Bigolin, Júlia Iaroseski, Randhall Bruce Carteri, Giovanna Severino Rodrigues, Rafaela de Andrade, Luiz Alberto De Carli, Elisa Loch Razzera, Izabele Vian, Roberta de Almeida da Silva, Antônio Nocchi Kalil, Luis Fernando Ferreira

Zitieren

APA

Bigolin, A. V., Iaroseski, J., Carteri, R. B., Rodrigues, G. S., de Andrade, R., De Carli, L. A., Razzera, E. L., Vian, I., de Almeida da Silva, R., Kalil, A. N., & Ferreira, L. F. (2026). Effects of Omega‐3 Supplementation in Sarcopenia After Bariatric Surgery: A Triple‐Blind Randomized Controlled Clinical Trial. Journal of Cachexia, Sarcopenia and Muscle, 17(3). https://doi.org/10.1002/jcsm.70321

Vancouver

Bigolin AV, Iaroseski J, Carteri RB, Rodrigues GS, de Andrade R, De Carli LA, et al. Effects of Omega‐3 Supplementation in Sarcopenia After Bariatric Surgery: A Triple‐Blind Randomized Controlled Clinical Trial. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(3). doi:10.1002/jcsm.70321

BibTeX
@article{Bigolin2026,
  author = {Bigolin, André Vicente and Iaroseski, Júlia and Carteri, Randhall Bruce and Rodrigues, Giovanna Severino and de Andrade, Rafaela and De Carli, Luiz Alberto and Razzera, Elisa Loch and Vian, Izabele and de Almeida da Silva, Roberta and Kalil, Antônio Nocchi and Ferreira, Luis Fernando},
  title = {Effects of Omega‐3 Supplementation in Sarcopenia After Bariatric Surgery: A Triple‐Blind Randomized Controlled Clinical Trial},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1002/jcsm.70321}
}
Kostenlos starten →